Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Bio-Techne Corp. buy Stephens

Start price
€61.50
02.02.24 / 50%
Target price
€80.65
02.02.25
Performance (%)
16.26%
End price
€71.50
03.02.25
Summary
This prediction ended on 03.02.25 with a price of €71.50. The prediction had a final performance of 16.26%. Stephens has a follow-up prediction for Bio-Techne Corp. where he still thinks Bio-Techne Corp. is a Buy. A total of €0.30 was paid as dividends for this prediction. Stephens has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Bio-Techne Corp. -5.600% -5.600% -30.074%
iShares Core DAX® -1.351% 0.610% 37.046%
iShares Nasdaq 100 -1.453% 3.019% 22.196%
iShares Nikkei 225® -0.021% 1.195% 12.929%
iShares S&P 500 -1.326% 2.830% 16.099%

Comments by Stephens for this prediction

In the thread Bio-Techne Corp. diskutieren
Prediction Buy
Perf. (%) 16.26%
Target price 80.649
Change
Ends at 02.02.25

Bio-Techne Co. (NASDAQ: TECH) had its price target lowered by analysts at Stephens from $92.00 to $87.00. They now have an "overweight" rating on the stock.
Ratings data for TECH provided by MarketBeat

In the thread Trading Bio-Techne Corp.
Prediction Buy
Perf. (%) 16.26%
Target price 80.649
Change
Ends at 02.02.25

Die von Stephens gewählte maximale Laufzeit wurde überschritten

Current prediction by Stephens for Bio-Techne Corp.

buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€45.20
22.07.25
€55.60
22.07.26
-6.64%
19:44